On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Brain Protein May Inhibit Relapse in Cocaine Addiction
Mice which were previously self-administering cocaine were less likely to go back to the habit after a period of abstinence, during which brain proteins were measured, according to a report published in Molecular Psychiatry.
Distal Radius Fracture: Still No Definitive Treatment Preference
November 28th 2014Distal radius fracture-also called a wrist fracture by patients-is common. Its incidence is expected to increase in the next 20 years, since our population is aging and the risk of this specific fracture increases in patients with metabolic disorders, including osteoporosis. However, the health care community has yet to reach a consensus regarding indications for surgery, and there is insufficient data to identify a preferred operative technique.
Listening to Feedback, Increasing Surgeons' Pay
November 28th 2014Team-based feedback has the potential to improve surgeons' relationships with coworkers and patients. The clinical implication: using such feedback to improve less-than-optimal behaviors could increase practice reimbursement under the "pay-for-professionalism" system.
Limiting Orthopedic Residents' Work Hours: 15 Years of Data, No Clear Effect
November 28th 2014Supporters of a duty-hour limits in the surgical suite to 80 hours/week say that patient safety is improved. Opponents claim that limiting resident duty-hours jeopardizes resident education and preparedness.
COPD, Asthma May Increase Risk for Inflammatory Bowel Disease
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
FDA Grants Dupilumab Breakthrough Therapy Designation in Atopic Dermatitis
Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.
Researchers Devise a Reliable Test for Wheat-Dependent Exercise-Induced Anaphylaxis
Researchers from Germany believe they have improved upon current methods for diagnosing wheat-dependent exercise-induced anaphylaxis (WDEIA) - and demonstrated that the condition isn't necessarily induced by exercise.
Can We Preserve Cognitive Function in Patients with Atrial Fibrillation?
Despite much evidence that atrial fibrillation (AF) greatly increases the risk of cognitive decline, a review of research to date finds little compelling support for any particular strategies to minimize that risk.
Correcting Short Stature: Long-Term Risks May Include Stroke
November 23rd 2014Early reports from the Safety and Appropriateness of Growth hormone treatments in Europe (SAGhE) project noted increased cardiac and cerebrovascular mortality in adults who were treated for stature problems as children. In addition, other studies have linked stroke risk to short stature in general, hypothesizing that shorter people have increased metabolic risks.
Diabetes and Famine: Some Findings Clinically Applicable
November 23rd 2014Endocrinologists generally see middle-aged people who have developed type 2 diabetes mellitus (T2DM) subsequent to overnutrition (or overeating) and weight gain. Most clinicians tend to forget that low caloric intake, or undernutrition, in the prenatal period or during a child's formative years also seems to increase the risk of the T2DM later in life.
Advanced Colorectal Cancer: 3 Drugs Are Better Than One
Patients with advanced colorectal cancer previously only had access to limited treatment options; however, new research presented at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, indicated a combination of 3 targeted drugs could potentially serve as a successful treatment.
Hopeful Study Results for Patients with Cirrhosis and Hepatitis C
November 21st 2014Patients with cirrhosis who took part in a study that tested a triple combination drug for hepatitis C with ribavirin saw normalization of key laboratory tests after three and six month treatment periods, an indication of improved liver condition.